Cargando…

Comorbidities and COPD severity in a clinic-based cohort

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality around the world. The aim of our study was to determine the association between specific comorbidities and COPD severity. METHODS: Pulmonologists included patients with COPD using a web-site que...

Descripción completa

Detalles Bibliográficos
Autores principales: Raherison, Chantal, Ouaalaya, El-Hassane, Bernady, Alain, Casteigt, Julien, Nocent-Eijnani, Cecilia, Falque, Laurent, Le Guillou, Frédéric, Nguyen, Laurent, Ozier, Annaig, Molimard, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048834/
https://www.ncbi.nlm.nih.gov/pubmed/30012144
http://dx.doi.org/10.1186/s12890-018-0684-7
_version_ 1783340171260854272
author Raherison, Chantal
Ouaalaya, El-Hassane
Bernady, Alain
Casteigt, Julien
Nocent-Eijnani, Cecilia
Falque, Laurent
Le Guillou, Frédéric
Nguyen, Laurent
Ozier, Annaig
Molimard, Mathieu
author_facet Raherison, Chantal
Ouaalaya, El-Hassane
Bernady, Alain
Casteigt, Julien
Nocent-Eijnani, Cecilia
Falque, Laurent
Le Guillou, Frédéric
Nguyen, Laurent
Ozier, Annaig
Molimard, Mathieu
author_sort Raherison, Chantal
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality around the world. The aim of our study was to determine the association between specific comorbidities and COPD severity. METHODS: Pulmonologists included patients with COPD using a web-site questionnaire. Diagnosis of COPD was made using spirometry post-bronchodilator FEV1/FVC < 70%. The questionnaire included the following domains: demographic criteria, clinical symptoms, functional tests, comorbidities and therapeutic management. COPD severity was classified according to GOLD 2011. First we performed a principal component analysis and a non-hierarchical cluster analysis to describe the cluster of comorbidities. RESULTS: One thousand, five hundred and eighty-four patients were included in the cohort during the first 2 years. The distribution of COPD severity was: 27.4% in group A, 24.7% in group B, 11.2% in group C, and 36.6% in group D. The mean age was 66.5 (sd: 11), with 35% of women. Management of COPD differed according to the comorbidities, with the same level of severity. Only 28.4% of patients had no comorbidities associated with COPD. The proportion of patients with two comorbidities was significantly higher (p < 0.001) in GOLD B (50.4%) and D patients (53.1%) than in GOLD A (35.4%) and GOLD C ones (34.3%). The cluster analysis showed five phenotypes of comorbidities: cluster 1 included cardiac profile; cluster 2 included less comorbidities; cluster 3 included metabolic syndrome, apnea and anxiety-depression; cluster 4 included denutrition and osteoporosis and cluster 5 included bronchiectasis. The clusters were mostly significantly associated with symptomatic patients i.e. GOLD B and GOLD D. CONCLUSIONS: This study in a large real-life cohort shows that multimorbidity is common in patients with COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-018-0684-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6048834
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60488342018-07-19 Comorbidities and COPD severity in a clinic-based cohort Raherison, Chantal Ouaalaya, El-Hassane Bernady, Alain Casteigt, Julien Nocent-Eijnani, Cecilia Falque, Laurent Le Guillou, Frédéric Nguyen, Laurent Ozier, Annaig Molimard, Mathieu BMC Pulm Med Research Article BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality around the world. The aim of our study was to determine the association between specific comorbidities and COPD severity. METHODS: Pulmonologists included patients with COPD using a web-site questionnaire. Diagnosis of COPD was made using spirometry post-bronchodilator FEV1/FVC < 70%. The questionnaire included the following domains: demographic criteria, clinical symptoms, functional tests, comorbidities and therapeutic management. COPD severity was classified according to GOLD 2011. First we performed a principal component analysis and a non-hierarchical cluster analysis to describe the cluster of comorbidities. RESULTS: One thousand, five hundred and eighty-four patients were included in the cohort during the first 2 years. The distribution of COPD severity was: 27.4% in group A, 24.7% in group B, 11.2% in group C, and 36.6% in group D. The mean age was 66.5 (sd: 11), with 35% of women. Management of COPD differed according to the comorbidities, with the same level of severity. Only 28.4% of patients had no comorbidities associated with COPD. The proportion of patients with two comorbidities was significantly higher (p < 0.001) in GOLD B (50.4%) and D patients (53.1%) than in GOLD A (35.4%) and GOLD C ones (34.3%). The cluster analysis showed five phenotypes of comorbidities: cluster 1 included cardiac profile; cluster 2 included less comorbidities; cluster 3 included metabolic syndrome, apnea and anxiety-depression; cluster 4 included denutrition and osteoporosis and cluster 5 included bronchiectasis. The clusters were mostly significantly associated with symptomatic patients i.e. GOLD B and GOLD D. CONCLUSIONS: This study in a large real-life cohort shows that multimorbidity is common in patients with COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-018-0684-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-16 /pmc/articles/PMC6048834/ /pubmed/30012144 http://dx.doi.org/10.1186/s12890-018-0684-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Raherison, Chantal
Ouaalaya, El-Hassane
Bernady, Alain
Casteigt, Julien
Nocent-Eijnani, Cecilia
Falque, Laurent
Le Guillou, Frédéric
Nguyen, Laurent
Ozier, Annaig
Molimard, Mathieu
Comorbidities and COPD severity in a clinic-based cohort
title Comorbidities and COPD severity in a clinic-based cohort
title_full Comorbidities and COPD severity in a clinic-based cohort
title_fullStr Comorbidities and COPD severity in a clinic-based cohort
title_full_unstemmed Comorbidities and COPD severity in a clinic-based cohort
title_short Comorbidities and COPD severity in a clinic-based cohort
title_sort comorbidities and copd severity in a clinic-based cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048834/
https://www.ncbi.nlm.nih.gov/pubmed/30012144
http://dx.doi.org/10.1186/s12890-018-0684-7
work_keys_str_mv AT raherisonchantal comorbiditiesandcopdseverityinaclinicbasedcohort
AT ouaalayaelhassane comorbiditiesandcopdseverityinaclinicbasedcohort
AT bernadyalain comorbiditiesandcopdseverityinaclinicbasedcohort
AT casteigtjulien comorbiditiesandcopdseverityinaclinicbasedcohort
AT nocenteijnanicecilia comorbiditiesandcopdseverityinaclinicbasedcohort
AT falquelaurent comorbiditiesandcopdseverityinaclinicbasedcohort
AT leguilloufrederic comorbiditiesandcopdseverityinaclinicbasedcohort
AT nguyenlaurent comorbiditiesandcopdseverityinaclinicbasedcohort
AT ozierannaig comorbiditiesandcopdseverityinaclinicbasedcohort
AT molimardmathieu comorbiditiesandcopdseverityinaclinicbasedcohort